Biome First Half FY26 Results and Highlights
Filed with ASX · · 7 pages · English
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings Call● Fastest growing probiotic brand in Australian community pharmacy, with 100% of the product range in growth ● #2 ranked brand across total vitamins at Terry White Chemmart and the fastest growing in the category ● First major above-the-line winter immunity campaign in development for H2 ● Fullscript distribution partnership secured in Canada (announced January 2026) ● Ethics approval granted for
In the deck
Story so far
Earlier from Biome Australia
- Appendix 4D & Half Yearly Report
- Ethics Approval Granted for BMB18 Human Clinical Trial
- Biome secures distribution with Fullscript Canada
- Quarterly Activities & Cashflow Report
- Trading Update
Later from Biome Australia
- Patent Application Filed for Probiotic Strain BMB18
- Probiotical Exclusive Supply Agreement Extended
- BMB18 clinical trial expands to dual site
- Biome Signs Australian Manufacturing Agreement
- FY26 Trading Update
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia